15 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
encephalitis • Mycobacterium ... • Disseminated Mycobacterium ... avium complex (MAC ... HIVAIDS #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
encephalitis • Mycobacterium ... • Disseminated Mycobacterium ... avium complex (MAC ... HIVAIDS #IDSA #management ... #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
please refer to Table ... 5 for dosing recommendation ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Please refer to the table ... #LTBI #Mycobacterium ... Tuberculosis #TB #IDSA #Prevention ... #Treatment #management ... #HIVAIDS #pharmacology
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the ... Treatment of COVID-19 Infection ... macular disease, may ... Treatment #COVID19 #Pharmacology ... #Table #Management
Aplastic Anemia - Overview

Who?
• M = F
• 3 peaks:	1) Childhood	2) 15-25 years	3) >60 years

What?
• Aplastic anemia
- Cytotoxic drugs ... Idiopathic • Infections ... Parvovirus B19 • Mycobacteria ... symptoms that may ... hematology #diagnosis #management
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
in HIV-AIDS Preventing ... best prevented by using ... intraocular levels of drug ... #Treatment #management ... #HIVAIDS #pharmacology
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
immune system may ... nephritis, fevers • MAC ... organizing PNA • Mycobacterium ... /drug resistance ... Differential #Diagnosis #Management
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... order for the drug ... to remain stable ... also because this may ... semaglutide #Diabetes #Pharmacology
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
then be excreted using ... then placed on prevention ... differential #algorithm #management ... cardiology #treatment #table ... icu #clinical #pharmacology